ArticlebioRxiv : the preprint server for biology2026
LinkLlama: Enabling Large Language Model for Chemically Reasonable Linker Design.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
6 authors.
Funding
Abstract
Fragment-based drug discovery (FBDD) relies heavily on the design of chemically viable linkers to connect fragments binding to different pocket regions into potent lead molecules. While recent generative models have advanced spatial fragment linking, they frequently produce linkers characterized by high torsional strain and non-drug-like motifs. In this work, we present LinkLlama, a fine-tuned Meta Llama 3 model that bridges the gap between text-based generation and 3D spatial awareness. By accepting natural language prompts that specify geometric constraints, such as distances and angles, alongside physicochemical targets like Lipinski's rules and rotatable bond limits, LinkLlama generates highly tailored molecules for the input fragments. Leveraging the inherent chemical grammar captured through supervised fine-tuning on a curated corpus of drug-like molecules from ChEMBL, the model prioritizes chemical validity without requiring complex reinforcement learning loops. Benchmarking on the ZINC and HiQBind datasets demonstrates that LinkLlama maintains competitive geometric fidelity compared to strictly 3D-aware models while achieving a two-fold increase in the proportion of chemically reasonable designs. This rising success rate, jumping from 35% to over 80%, is defined by strict adherence to comprehensive structural filters including PAINS, non-drug-like chemical patterns and complex ring systems. We further illustrate the model's versatility through prospective case studies in novel small-molecule scaffold hopping and PROTAC linker design, validated via molecular docking and molecular dynamics simulations against known crystal poses. Ultimately, LinkLlama demonstrates that large language models can overcome the structural pitfalls of purely 3D-generative methods, offering a highly controllable and chemically robust framework to accelerate linker design and drug discovery in general.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.